World

Canada loses measles elimination status after year-long outbreak

Nov 11, 2025

Ottawa [Canada], November 11: The Public Health Agency of Canada said Monday that the country has lost its measles elimination status.
In a statement, the Canadian agency said it was notified about the change of status by the Pan American Health Organization, after verifying that the same strain of the measles virus has been continuously transmitted within the country for over a year.
According to the statement, Canada is currently experiencing a large, multi-jurisdictional outbreak of measles that began in October 2024.
As of Oct. 25, 2025, a cumulative total of 5,138 measles cases have been reported across the country this year, said a weekly report monitoring measles and rubella issued by the Canadian government, adding that two deaths have been reported, both in premature infants with congenital measles.
Canada previously achieved measles elimination status in 1998.
While transmission has slowed recently, the outbreak has persisted for over 12 months, primarily within under-vaccinated communities, the agency said.
It noted that Canada can re-establish its measles elimination status once transmission of the current outbreak's measles strain is interrupted for at least 12 months.
Measles is an acute and highly contagious viral respiratory illness, primarily spread through respiratory droplets and aerosols. Symptoms including high fever, cough, runny nose, red and watery eyes, and a characteristic rash usually appear one to two weeks after exposure. Severe cases can lead to complications such as pneumonia.
Source: Xinhua News Agency

More news

Infosys: Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues

Bengaluru (Karnataka) [India], October 23: Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in AI-first business consulting and technology services, delivered $5,145 million in Q2 revenues, year on year growth of 1.5% and sequential growth of 1.2% in constant currency. Operating margin was stable at 21.0%. EPS growth was 8.7% year on year in rupee terms. TCV of large deal wins was $5.2 billion, with 62% net new. Robust Q2 large deal TCV at $5.2 billion with 62% net new; lays solid foundation for future growth. FY 27 revenue guidance revised to 1%-2% and margin guidance retained at 20%-22%.

Oct 23, 2026